Rezolute Inc reports results for the quarter ended December 31 - Earnings Summary

Rezolute

12/02/2025 22:15

* Rezolute Inc  RZLT.OQ  reported a quarterly adjusted loss
of 22
cents​​ per share for the quarter ended December 31, higher than
the same quarter last year, when the company reported EPS of -27
cents.  The mean expectation of nine analysts for the quarter
was for a loss of 25 cents per share. Wall Street expected
results to range from -30 cents to -23 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Rezolute Inc's reported EPS for the quarter was a loss
of 22
cents​.
    * The company reported a quarterly loss of $15.73 million.
    * Rezolute Inc shares had fallen by 2.4% this quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 10 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Rezolute Inc is
$13.00 
This summary was machine generated from LSEG data February 12 at
10:14 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2024      -0.25          -0.22          Beat
 Sep. 30 2024      -0.33          -0.22          Beat
 Jun. 30 2024      -0.33          -0.44          Missed
 Mar. 31 2024      -0.30          -0.34          Missed